The sweating apparatus in growth hormone deficiency, following treatment with r-hGH and in acromegaly

Wohaib Hasan, Timothy Cowen, Philip S. Barnett, Emma Elliot, Patsy Coskeran, Pierre M G Bouloux

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Adult growth hormone deficient patients are known to exhibit reduced sweating and their ability to thermoregulate is diminished. Treatment of these patients with recombinant human growth hormone (r-hGH) is claimed to reverse these abnormalities. We have investigated this claim, as well as the mechanism underlying these altered sweating responses in GH-deficient patients as part of a placebo-controlled study on the effects of 6-12 months r-hGH therapy. Skin biopsies were obtained from these subjects and changes in morphology and innervation parameters for the eccrine sweat glands were examined. These included histochemistry for acetylcholinesterase (AChE) and immunohistochemistry for the neuropeptide vasoactive intestinal polypeptide (VIP) and for PGP9.5, a general neuronal marker. Sweat gland acinar size and periacinar innervation were measured by computerised image analysis. The patients underwent pilocarpine iontophoresis sweat rate tests and their serum insulin-like growth factor 1 (IGF-1) levels were assessed. Since active acromegaly involves excess GH secretion and hyperhidrosis, skin biopsies and sweat tests were also carried out on a group of these patients, as well as on control subjects. We have demonstrated a sweating defect in adult GH-deficiency which is accompanied by a reduction in AChE and VIP levels in the nerve supply to sweat glands. Following r-hGH therapy, an increase in AChE and VIP staining is seen in the sudomotor nerves accompanied by restoration of sweat rates and serum IGF-1 levels. Hence, normalization of sweat gland function includes recovery of sudomotor synapse constituents. A trophic effect of GH on sweat gland epithelium and/or on the associated nerves is proposed, supported by the observation that in acromegaly the size of sweat gland acini and the density of innervation to the sweat glands was greater than in controls.

Original languageEnglish (US)
Pages (from-to)100-109
Number of pages10
JournalAutonomic Neuroscience: Basic and Clinical
Volume89
Issue number1-2
DOIs
StatePublished - Jun 20 2001
Externally publishedYes

Fingerprint

Sweat Glands
Acromegaly
Sweating
Human Growth Hormone
Growth Hormone
Sweat
Vasoactive Intestinal Peptide
Acetylcholinesterase
Somatomedins
Therapeutics
Eccrine Glands
Hyperhidrosis
Biopsy
Iontophoresis
Skin
Pilocarpine
Recovery of Function
Neuropeptides
Serum
Synapses

Keywords

  • Acromegaly
  • Adult growth hormone deficiency
  • Autonomic nerves
  • Growth hormone
  • Insulin-like growth factor
  • Neuronal plasticity
  • Sweat gland innervation
  • Sweating
  • Sympathetic nerves
  • Vasoactive intestinal polypeptide

ASJC Scopus subject areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Endocrine and Autonomic Systems

Cite this

The sweating apparatus in growth hormone deficiency, following treatment with r-hGH and in acromegaly. / Hasan, Wohaib; Cowen, Timothy; Barnett, Philip S.; Elliot, Emma; Coskeran, Patsy; Bouloux, Pierre M G.

In: Autonomic Neuroscience: Basic and Clinical, Vol. 89, No. 1-2, 20.06.2001, p. 100-109.

Research output: Contribution to journalArticle

Hasan, Wohaib ; Cowen, Timothy ; Barnett, Philip S. ; Elliot, Emma ; Coskeran, Patsy ; Bouloux, Pierre M G. / The sweating apparatus in growth hormone deficiency, following treatment with r-hGH and in acromegaly. In: Autonomic Neuroscience: Basic and Clinical. 2001 ; Vol. 89, No. 1-2. pp. 100-109.
@article{adb4e971d7124d7b88957ade19a475f4,
title = "The sweating apparatus in growth hormone deficiency, following treatment with r-hGH and in acromegaly",
abstract = "Adult growth hormone deficient patients are known to exhibit reduced sweating and their ability to thermoregulate is diminished. Treatment of these patients with recombinant human growth hormone (r-hGH) is claimed to reverse these abnormalities. We have investigated this claim, as well as the mechanism underlying these altered sweating responses in GH-deficient patients as part of a placebo-controlled study on the effects of 6-12 months r-hGH therapy. Skin biopsies were obtained from these subjects and changes in morphology and innervation parameters for the eccrine sweat glands were examined. These included histochemistry for acetylcholinesterase (AChE) and immunohistochemistry for the neuropeptide vasoactive intestinal polypeptide (VIP) and for PGP9.5, a general neuronal marker. Sweat gland acinar size and periacinar innervation were measured by computerised image analysis. The patients underwent pilocarpine iontophoresis sweat rate tests and their serum insulin-like growth factor 1 (IGF-1) levels were assessed. Since active acromegaly involves excess GH secretion and hyperhidrosis, skin biopsies and sweat tests were also carried out on a group of these patients, as well as on control subjects. We have demonstrated a sweating defect in adult GH-deficiency which is accompanied by a reduction in AChE and VIP levels in the nerve supply to sweat glands. Following r-hGH therapy, an increase in AChE and VIP staining is seen in the sudomotor nerves accompanied by restoration of sweat rates and serum IGF-1 levels. Hence, normalization of sweat gland function includes recovery of sudomotor synapse constituents. A trophic effect of GH on sweat gland epithelium and/or on the associated nerves is proposed, supported by the observation that in acromegaly the size of sweat gland acini and the density of innervation to the sweat glands was greater than in controls.",
keywords = "Acromegaly, Adult growth hormone deficiency, Autonomic nerves, Growth hormone, Insulin-like growth factor, Neuronal plasticity, Sweat gland innervation, Sweating, Sympathetic nerves, Vasoactive intestinal polypeptide",
author = "Wohaib Hasan and Timothy Cowen and Barnett, {Philip S.} and Emma Elliot and Patsy Coskeran and Bouloux, {Pierre M G}",
year = "2001",
month = "6",
day = "20",
doi = "10.1016/S1566-0702(01)00257-0",
language = "English (US)",
volume = "89",
pages = "100--109",
journal = "Autonomic Neuroscience: Basic and Clinical",
issn = "1566-0702",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - The sweating apparatus in growth hormone deficiency, following treatment with r-hGH and in acromegaly

AU - Hasan, Wohaib

AU - Cowen, Timothy

AU - Barnett, Philip S.

AU - Elliot, Emma

AU - Coskeran, Patsy

AU - Bouloux, Pierre M G

PY - 2001/6/20

Y1 - 2001/6/20

N2 - Adult growth hormone deficient patients are known to exhibit reduced sweating and their ability to thermoregulate is diminished. Treatment of these patients with recombinant human growth hormone (r-hGH) is claimed to reverse these abnormalities. We have investigated this claim, as well as the mechanism underlying these altered sweating responses in GH-deficient patients as part of a placebo-controlled study on the effects of 6-12 months r-hGH therapy. Skin biopsies were obtained from these subjects and changes in morphology and innervation parameters for the eccrine sweat glands were examined. These included histochemistry for acetylcholinesterase (AChE) and immunohistochemistry for the neuropeptide vasoactive intestinal polypeptide (VIP) and for PGP9.5, a general neuronal marker. Sweat gland acinar size and periacinar innervation were measured by computerised image analysis. The patients underwent pilocarpine iontophoresis sweat rate tests and their serum insulin-like growth factor 1 (IGF-1) levels were assessed. Since active acromegaly involves excess GH secretion and hyperhidrosis, skin biopsies and sweat tests were also carried out on a group of these patients, as well as on control subjects. We have demonstrated a sweating defect in adult GH-deficiency which is accompanied by a reduction in AChE and VIP levels in the nerve supply to sweat glands. Following r-hGH therapy, an increase in AChE and VIP staining is seen in the sudomotor nerves accompanied by restoration of sweat rates and serum IGF-1 levels. Hence, normalization of sweat gland function includes recovery of sudomotor synapse constituents. A trophic effect of GH on sweat gland epithelium and/or on the associated nerves is proposed, supported by the observation that in acromegaly the size of sweat gland acini and the density of innervation to the sweat glands was greater than in controls.

AB - Adult growth hormone deficient patients are known to exhibit reduced sweating and their ability to thermoregulate is diminished. Treatment of these patients with recombinant human growth hormone (r-hGH) is claimed to reverse these abnormalities. We have investigated this claim, as well as the mechanism underlying these altered sweating responses in GH-deficient patients as part of a placebo-controlled study on the effects of 6-12 months r-hGH therapy. Skin biopsies were obtained from these subjects and changes in morphology and innervation parameters for the eccrine sweat glands were examined. These included histochemistry for acetylcholinesterase (AChE) and immunohistochemistry for the neuropeptide vasoactive intestinal polypeptide (VIP) and for PGP9.5, a general neuronal marker. Sweat gland acinar size and periacinar innervation were measured by computerised image analysis. The patients underwent pilocarpine iontophoresis sweat rate tests and their serum insulin-like growth factor 1 (IGF-1) levels were assessed. Since active acromegaly involves excess GH secretion and hyperhidrosis, skin biopsies and sweat tests were also carried out on a group of these patients, as well as on control subjects. We have demonstrated a sweating defect in adult GH-deficiency which is accompanied by a reduction in AChE and VIP levels in the nerve supply to sweat glands. Following r-hGH therapy, an increase in AChE and VIP staining is seen in the sudomotor nerves accompanied by restoration of sweat rates and serum IGF-1 levels. Hence, normalization of sweat gland function includes recovery of sudomotor synapse constituents. A trophic effect of GH on sweat gland epithelium and/or on the associated nerves is proposed, supported by the observation that in acromegaly the size of sweat gland acini and the density of innervation to the sweat glands was greater than in controls.

KW - Acromegaly

KW - Adult growth hormone deficiency

KW - Autonomic nerves

KW - Growth hormone

KW - Insulin-like growth factor

KW - Neuronal plasticity

KW - Sweat gland innervation

KW - Sweating

KW - Sympathetic nerves

KW - Vasoactive intestinal polypeptide

UR - http://www.scopus.com/inward/record.url?scp=0035919247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035919247&partnerID=8YFLogxK

U2 - 10.1016/S1566-0702(01)00257-0

DO - 10.1016/S1566-0702(01)00257-0

M3 - Article

VL - 89

SP - 100

EP - 109

JO - Autonomic Neuroscience: Basic and Clinical

JF - Autonomic Neuroscience: Basic and Clinical

SN - 1566-0702

IS - 1-2

ER -